Table of Contents
Asian Journal of Neuroscience
Volume 2013, Article ID 909767, 6 pages
http://dx.doi.org/10.1155/2013/909767
Research Article

Molecular Diagnosis of Friedreich Ataxia Using Analysis of GAA Repeats and FXN Gene Exons in Population from Western India

Department of Molecular Medicine & Biology, Jaslok Hospital & Research Centre, 15 Dr. G. Deshmukh Marg, Mumbai 400026, Maharashtra, India

Received 15 July 2013; Accepted 21 August 2013

Academic Editors: Y. Kuroiwa, F. Saccà, and C. E. Wang

Copyright © 2013 Pravin D. Potdar and Aarthy Raghu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. B. Delatycki, R. Williamson, and S. M. Forrest, “Friedreich ataxia: an overview,” Journal of Medical Genetics, vol. 37, no. 1, pp. 1–8, 2000. View at Google Scholar · View at Scopus
  2. V. Campuzano, L. Montermini, M. D. Moltò et al., “Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion,” Science, vol. 271, no. 5254, pp. 1423–1427, 1996. View at Google Scholar · View at Scopus
  3. V. Campuzano, L. Montermini, Y. Lutz et al., “Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes,” Human Molecular Genetics, vol. 6, no. 11, pp. 1771–1780, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. D.-P. Sirano, R. Shigeta, Y.-I. Chi, M. Ristow, and S. E. Shoelson, “Crystal structure of human frataxin,” Journal of Biological Chemistry, vol. 275, no. 40, pp. 30753–30756, 2000. View at Google Scholar · View at Scopus
  5. E. A. Roman, S. E. Faraj, M. Gallo, A. G. Salvay, D. U. Ferreiro, and J. Santos, “Protein stability and dynamics modulation: the case of human frataxin,” PLoS ONE, vol. 7, article e45743, 2012. View at Google Scholar
  6. S. Schmucker, A. Martelli, F. Colin et al., “Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex,” PLoS ONE, vol. 6, no. 1, article e16199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Sakamoto, K. Ohshima, L. Montermini, M. Pandolfo, and R. D. Wells, “Sticky DNA, a self-associated complex formed at long GAA·TTC repeats in intron 1 of the frataxin gene, inhibits transcription,” Journal of Biological Chemistry, vol. 276, no. 29, pp. 27171–27177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Ohshima, L. Montermini, R. D. Wells, and M. Pandolfo, “Inhibitory effects of expanded GAA·TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo,” Journal of Biological Chemistry, vol. 273, no. 23, pp. 14588–14595, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. I. Bidichandani, T. Ashizawa, and P. I. Patel, “The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure,” American Journal of Human Genetics, vol. 62, no. 1, pp. 111–121, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Grabczyk, M. Mancuso, and M. C. Sammarco, “A persistent RNA·DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro,” Nucleic Acids Research, vol. 35, no. 16, pp. 5351–5359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. D. Wells, “DNA triplexes and Friedreich ataxia,” FASEB Journal, vol. 22, no. 6, pp. 1625–1634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Harding, “Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features,” Brain, vol. 104, no. 3, pp. 589–620, 1981. View at Google Scholar · View at Scopus
  13. S. Kocheva, S. Trivodalieva, S. Vlaski-Jekic, M. Kuturec, and G. D. Efremov, “Molecular analysis of Friedreich's ataxia in Macedonian patients,” Balkan Journal of Medical Genetics, vol. 11, no. 1, pp. 61–64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Zühlke, A. Dalski, M. Habeck et al., “Extension of the mutation spectrum in Friedreich's ataxia: detection of an exon deletion and novel missense mutations,” European Journal of Human Genetics, vol. 12, no. 11, pp. 979–982, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. P. J. Lamont, M. B. Davis, and N. W. Wood, “Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients. Clinical and genetic correlates,” Brain, vol. 120, no. 4, pp. 673–680, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Filla, G. De Michele, F. Cavalcanti et al., “The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia,” American Journal of Human Genetics, vol. 59, no. 3, pp. 554–560, 1996. View at Google Scholar · View at Scopus
  17. C. Cagnoli, C. Michielotto, T. Matsuura et al., “Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay,” Journal of Molecular Diagnostics, vol. 6, no. 2, pp. 96–100, 2004. View at Google Scholar · View at Scopus
  18. P. Ciotti, E. Di Maria, E. Bellone, F. Ajmar, and P. Mandich, “Triplet repeat primed PCR (TP PCR) in molecular diagnostic testing for Friedreich ataxia,” Journal of Molecular Diagnostics, vol. 6, no. 4, pp. 285–289, 2004. View at Google Scholar · View at Scopus
  19. A. Dürr, M. Cossee, Y. Agid et al., “Clinical and genetic abnormalities in patients with Friedreich's ataxia,” The New England Journal of Medicine, vol. 335, no. 16, pp. 1169–1175, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Pianese, M. Turano, M. S. Lo Casale et al., “Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 7, pp. 1061–1063, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Willis, G. Isaya, O. Gakh, R. A. Capaldi, and M. F. Marusich, “Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers,” Molecular Genetics and Metabolism, vol. 94, no. 4, pp. 491–497, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. C. Deutsch, A. B. Santani, S. L. Perlman et al., “A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia,” Molecular Genetics and Metabolism, vol. 101, no. 2-3, pp. 238–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Saccà, G. Puorro, A. Antenora et al., “A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design,” PLoS ONE, vol. 6, no. 3, Article ID e17627, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Saccà, A. Marsili, G. Puorro et al., “Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene,” Journal of Neurology, vol. 260, no. 4, pp. 1116–1121, 2013. View at Google Scholar
  25. M. Naseroleslami, K. Parivar, S. Sanjarian, and E. Khalili, “Investigation of Exon 1 in FXN gene in patients with clinical symptomatic of Friedreich ataxia,” Qom University of Medical Sciences Journal, vol. 6, no. 4, pp. 1–7, 2013. View at Google Scholar
  26. M. L. McCormack, R. P. Guttmann, M. Schumann et al., “Frataxin point mutations in two patients with Friedreich's ataxia and unusual clinical features,” Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 5, pp. 661–664, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. S. D. Spacey, B. I. Szczygielski, S. P. Young, J. Hukin, K. Selby, and T. P. Snutch, “Malaysian siblings with Friedreich ataxia and chorea: a novel deletion in the frataxin gene,” Canadian Journal of Neurological Sciences, vol. 31, no. 3, pp. 383–386, 2004. View at Google Scholar · View at Scopus
  28. M. V. Evans-Galea, L. A. Corben, J. Hasell et al., “A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype,” Neurogenetics, vol. 12, no. 4, pp. 307–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. W. Van den Ouweland, R. van Minkelen, G. M. Bolman et al., “Complete FXN deletion in a patient with FRDA,” Genetic Testing and Molecular Biomarkers, vol. 16, pp. 1015–1018, 2012. View at Google Scholar
  30. I. Singh, M. Faruq, O. Mukherjee et al., “North and South Indian populations share a common ancestral origin of Friedreich's ataxia but vary in age of GAA repeat expansion,” Annals of Human Genetics, vol. 74, no. 3, pp. 202–210, 2010. View at Publisher · View at Google Scholar · View at Scopus